Work

Supplementary Figure 2 from Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia

Year: 2023

Type: supplementary-materials

Abstract: LEE011 remains antagonistic with methotrexate, mercaptopurine, L-asparaginase and doxorubicin when cells are treated sequentially with each drug combination.

DOI: 10.1158/1078-0432.22467161.v1

Authors: Yana Pikman, Gabriela Alexe, Giovanni Roti, Amy Saur Conway, Andrew Furman, Emily S. Lee, Andrew E. Place, Sunkyu Kim, Chitra Saran, Rebecca Modiste, David M. Weinstock, Marian Harris, Andrew L. Kung, Lewis B. Silverman, Kimberly Stegmaier

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361929687

Cites:

Cited by:

Related to: 10